Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Grossi

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Hematology & Oncology|November 29, 2013
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical applicationFederico Pozzo, Michele Dal Bo, Nadia Peragine, et al.
Stem Cell Research & Therapy|April 19, 2015
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party studyPellegrino Musto, Vittorio Simeon, Alberto Grossi, et al.
Leukemia & Lymphoma|July 9, 2013
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric surveyGiovanni D'Arena, Luca Laurenti, Marta Coscia, et al.
Leukemia Research|July 19, 2011
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemiaLuigi Gugliotta, Alessia Tieghi, Giovanni Tortorella, et al.
Leukemia & Lymphoma|January 7, 2016
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient programPier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, et al.
Blood|July 5, 2011
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, et al.
Blood|May 3, 2013
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemiaDavide Rossi, Valeria Spina, Riccardo Bomben, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Hematology & Oncology|November 29, 2013
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical applicationFederico Pozzo, Michele Dal Bo, Nadia Peragine, et al.
Stem Cell Research & Therapy|April 19, 2015
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party studyPellegrino Musto, Vittorio Simeon, Alberto Grossi, et al.
Leukemia & Lymphoma|July 9, 2013
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric surveyGiovanni D'Arena, Luca Laurenti, Marta Coscia, et al.
Leukemia Research|July 19, 2011
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemiaLuigi Gugliotta, Alessia Tieghi, Giovanni Tortorella, et al.
Leukemia & Lymphoma|January 7, 2016
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient programPier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, et al.
Blood|July 5, 2011
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, et al.
Blood|May 3, 2013
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemiaDavide Rossi, Valeria Spina, Riccardo Bomben, et al.
Pageof 5